Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole High Dose vs Low Dose for Ovarian Stimulation in PCOS
NCT07759518Completed
- Start
- Feb 2025
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Randomised trial of letrozole in polycystic ovary syndrome (PCOS) (2 arms). Primary endpoints: Presence of preovulatory follicle at 12 weeks and Multifollicular development at 12 weeks. Started Feb 2025; status: completed.
02
Drugs
letrozole
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07759518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07759518.